NHS digital tool aims to tackle obesity epidemic
NCT ID NCT07283978
First seen Dec 16, 2025 · Last updated Jun 22, 2026 · Updated 24 times
Summary
This study is testing a new digital weight management program for adults with obesity who are referred to NHS Tier 3 services. The program uses a smartphone app to help people manage their weight. Researchers want to see if it improves health, saves money, and works well for patients and doctors. About 580 participants will be followed for 12 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Guy' & St Thomas' NHS Foundation Trust
London, Greater London, SE1 9RT, United Kingdom
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Digital weight management programme
What this could lead to
If successful, this could provide an effective, scalable digital tool for managing obesity within the NHS, potentially improving health outcomes and reducing costs.
What could go wrong
This is an early-stage real-world study with no control group, so results may not prove the program works better than standard care. Success depends on patient engagement and technology access.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.